newsfilter
← Latest News
PR Newswire·

INVO Bioscience Reports Second Quarter 2022 Financial Results

Company to Host Conference Call Today at 4:30pm ET SARASOTA, Fla., Aug. 15, 2022 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ:INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on expanding access to advanced treatment world